CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $28.69M, above the global median of $18.73M
- FinancialsAltman Z-Score 4.07: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.14%Above 5Y avg (1.31%)
Annual Rate
CNY 0.60Paid annual
Payout Ratio
52.6%Sustainable
Payback Period
45.8 yr
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.79BCNY566.30M · vs all stocks (USD)
Trailing P/E
23.98xRevenue (TTM)
1.40BCNY209.20M · vs all stocks (USD)
Profit Margin
11.06%Beta
0.1290xvs all stocks
52-Week Change
2.94%vs all stocks
Market Capitalization
3.79BCNY566.30M · vs all stocks (USD)
Enterprise Value
3.64BCNY543.50M · vs all stocks (USD)
Trailing P/E
23.98xPrice to Sales (TTM)
2.64xPrice to Book (MRQ)
2.07xEnterprise to Revenue
2.60xEnterprise to EBITDA
11.91xGross Margin
27.73%Profit Margin
11.06%Operating Margin
12.64%Return on Assets (TTM)
4.64%Return on Equity (TTM)
8.70%Revenue (TTM)
1.40BCNY209.20M · vs all stocks (USD)
Revenue per Share (TTM)
10.30CNYUpdated Sep 22, 2026Quarterly Revenue Growth
18.30%Gross Profit (TTM)
389.67MCNY58.19M · vs all stocks (USD)
EBITDA (TTM)
195.79MCNY29.24M · vs all stocks (USD)
Net Income (TTM)
154.99MCNY23.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
8.20%Operating Cash Flow (TTM)
258.02MCNY38.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
192.14MCNY28.69M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.6000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
2.14%vs all stocks
5-Year Average Dividend Yield
1.31%vs all stocks
Payout Ratio
52.63%Minority Interest (Equity)
7.38MCNYFY2025 · Dec 31, 2025Revenue
1.34BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
955.04MCNYFY2025 · Dec 31, 2025Gross Profit
380.00MCNYFY2025 · Dec 31, 2025Operating Income
187.53MCNY28.00M · vs all stocks (USD)
Pre-tax Income
172.64MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.66MCNYFY2025 · Dec 31, 2025Net Income
148.99MCNYFY2025 · Dec 31, 2025EBIT
183.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
319.01MCNYFY2025 · Dec 31, 2025Research & Development
81.53MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
39.58MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
504.61KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
10.68MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.11CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.11CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
136.01MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
136.01MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
148.99MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.98MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-260.59MCNYFY2025 · Dec 31, 2025Free Cash Flow
-312.55MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
423.87MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
148.99MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-414.81MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.53MCNYFY2025 · Dec 31, 2025Capital Expenditures
-51.96MCNYFY2025 · Dec 31, 2025Purchase of Investments
-36.00MCNYFY2025 · Dec 31, 2025Sale of Investments
13.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.06MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
551.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-461.32MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-64.89MCNYFY2025 · Dec 31, 2025Other Financing Charges
-11.49MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
13.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
135.44MSharesUpdated Sep 22, 2026Float Shares
56.33MSharesUpdated Sep 22, 2026% Held by Insiders
61.49%vs all stocks
% Held by Institutions
5.44%vs all stocks
Total Cash (MRQ)
212.18MCNY31.69M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.57CNYUpdated Sep 22, 2026Total Debt (MRQ)
412.23MCNY61.56M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2292xCurrent Ratio (MRQ)
1.27xBook Value per Share (MRQ)
13.21CNYUpdated Sep 22, 2026Total Assets
2.59BCNY387.34M · vs all stocks (USD)
Total Current Assets
906.15MCNYFY2025 · Dec 31, 2025Total Liabilities
791.01MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.69BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
95.35MCNYFY2025 · Dec 31, 2025Total Current Liabilities
695.66MCNYFY2025 · Dec 31, 2025Cash
423.87MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
423.87MCNYFY2025 · Dec 31, 2025Accounts Receivable
200.27MCNYFY2025 · Dec 31, 2025Inventory
206.11MCNYFY2025 · Dec 31, 2025Accounts Payable
112.43MCNYFY2025 · Dec 31, 2025Short-term Debt
508.14MCNYFY2025 · Dec 31, 2025Other Current Liabilities
835.98KCNYFY2025 · Dec 31, 2025Long-term Debt
66.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
135.44MCNYFY2025 · Dec 31, 2025Retained Earnings
652.49MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY269.22M · vs all stocks (USD)
52-Week Low
21.90CNYUpdated Sep 22, 202652-Week High
30.80CNYUpdated Sep 22, 202652-Week Change
2.94%vs all stocks
Beta
0.1290xvs all stocks
50-Day MA
25.40CNYUpdated Sep 22, 2026200-Day MA
26.14CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.17MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.42MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
1.14CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.07: safe zoneNotable
Altman Z-Score: 4.07
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $28.69M, above the global median of $18.73MNotable
Levered free cash flow (USD): 28,692,249.475Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Neurogene Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Scitop Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Allogene Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Orient Gene Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Monopar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gujarat Themis Biosyn Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbang Save-Guard Group Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Celestica Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Climb Global Solutions Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth